McKesson Corporation (NYSE:MCK) has been assigned a $168.00 price target by analysts at Mizuho in a research note issued to investors on Tuesday. The brokerage currently has a “hold” rating on the stock. Mizuho’s target price would indicate a potential upside of 12.19% from the company’s previous close.

MCK has been the subject of several other research reports. Royal Bank Of Canada began coverage on shares of McKesson Corporation in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $168.00 price objective for the company. Jefferies Group LLC set a $165.00 price objective on shares of McKesson Corporation and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Cowen and Company raised shares of McKesson Corporation from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $176.00 to $189.00 in a research report on Tuesday, October 10th. UBS AG reissued a “neutral” rating and issued a $166.00 price objective (up previously from $156.00) on shares of McKesson Corporation in a research report on Monday, June 26th. Finally, Leerink Swann increased their price objective on shares of McKesson Corporation to $170.00 and gave the stock a “market perform” rating in a research report on Thursday, June 29th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $172.40.

Shares of McKesson Corporation (NYSE:MCK) opened at 149.75 on Tuesday. McKesson Corporation has a 12-month low of $114.53 and a 12-month high of $169.29. The firm has a market cap of $31.49 billion, a P/E ratio of 6.79 and a beta of 1.17. The company has a 50-day moving average of $151.80 and a 200 day moving average of $153.70.

McKesson Corporation (NYSE:MCK) last released its quarterly earnings data on Thursday, July 27th. The company reported $2.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.81 by ($0.35). McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. The business had revenue of $51.05 billion during the quarter, compared to analyst estimates of $51.22 billion. During the same period in the previous year, the company earned $3.50 EPS. McKesson Corporation’s revenue was up 2.7% on a year-over-year basis. Equities research analysts anticipate that McKesson Corporation will post $12.06 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/25/mckesson-corporation-mck-given-a-168-00-price-target-by-mizuho-analysts.html.

In other news, Director Marie L/Ca Knowles sold 1,083 shares of the firm’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $162.55, for a total value of $176,041.65. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO John H. Hammergren sold 99,000 shares of the firm’s stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $153.89, for a total transaction of $15,235,110.00. Following the completion of the transaction, the chief executive officer now owns 165,000 shares in the company, valued at $25,391,850. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 952,066 shares of company stock worth $145,736,987. Insiders own 1.20% of the company’s stock.

Several institutional investors have recently bought and sold shares of MCK. BlackRock Inc. lifted its position in shares of McKesson Corporation by 2,026.2% in the 1st quarter. BlackRock Inc. now owns 14,198,977 shares of the company’s stock worth $2,105,140,000 after buying an additional 13,531,173 shares during the last quarter. Ballentine Partners LLC bought a new position in shares of McKesson Corporation in the 1st quarter worth about $191,000. Parnassus Investments CA lifted its position in shares of McKesson Corporation by 310.0% in the 1st quarter. Parnassus Investments CA now owns 4,280,594 shares of the company’s stock worth $620,727,000 after buying an additional 3,236,594 shares during the last quarter. Capital Research Global Investors lifted its position in shares of McKesson Corporation by 27.3% in the 3rd quarter. Capital Research Global Investors now owns 11,486,482 shares of the company’s stock worth $1,915,371,000 after buying an additional 2,465,070 shares during the last quarter. Finally, Boston Partners lifted its position in shares of McKesson Corporation by 108.6% in the 2nd quarter. Boston Partners now owns 4,659,692 shares of the company’s stock worth $869,731,000 after buying an additional 2,425,685 shares during the last quarter. Institutional investors own 85.29% of the company’s stock.

McKesson Corporation Company Profile

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

Analyst Recommendations for McKesson Corporation (NYSE:MCK)

Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with MarketBeat.com's FREE daily email newsletter.